Integra LifeSciences has given its debt calendar a substantial extension. The price of that extra time includes a number that deserves a second look: 9.5% interest on a new $450 million bond issue.
Company News Premium
Integra Announces a $2.1 Billion Debt Restructuring
1 min read Premium comments

Integra LifeSciencesrefinancingIARTsenior secured notescredit agreementmedtech debtBank of America
Author
React:
